美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA070256"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0409-1215-01 0409-1215 HUMAN PRESCRIPTION DRUG Naloxone Hydrochloride NALOXONE HYDROCHLORIDE INJECTION, SOLUTION INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS 20050712 N/A ANDA ANDA070256 Hospira, Inc. NALOXONE HYDROCHLORIDE .4 mg/mL 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1215-01) / 1 mL in 1 VIAL, SINGLE-DOSE (0409-1215-21)
51662-1242-1 51662-1242 HUMAN PRESCRIPTION DRUG NALOXONE HCI NALOXONE HCI INJECTION, SOLUTION INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS 20180818 N/A ANDA ANDA070256 HF Acquisition Co. LLC, DBA Health First NALOXONE HYDROCHLORIDE .4 mg/mL 1 mL in 1 VIAL (51662-1242-1)
51662-1242-3 51662-1242 HUMAN PRESCRIPTION DRUG NALOXONE HCI NALOXONE HCI INJECTION, SOLUTION INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS 20200615 N/A ANDA ANDA070256 HF Acquisition Co. LLC, DBA Health First NALOXONE HYDROCHLORIDE .4 mg/mL 50 POUCH in 1 CASE (51662-1242-3) / 1 mL in 1 POUCH (51662-1242-2)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase